arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TransMedics Group, Inc.

TMDX

$83.92 ▲ +3.68 (+4.59%) at close

9 Visible periods

33 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

TransMedics Group, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.9B

Dividend Yield —

Revenue Growth 37.1% ↘

Op. Margin 17.9% ↗

ROIC 40.6% ↗

FCF / Share $3.93 ↗

Trailing P/E 15.0x

Price / Book 6.1x

FCF Yield 4.7%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$605.49M

↑ +37.1% —

Net Income Profit after all expenses

$190.29M

↑ +436.6% —

Operating Margin Operating profit as % of sales

17.9%

↑ +111.2% 72th

FCF / Share Free cash flow per share

$3.93

↑ +261.3% —

Long-Term Debt Long-term obligations

$58.70M

↑ +66.8% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Financial Health

Cash Quality →

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2017

FY 2018

$0.00

FY 2019

FY 2020

$0.00

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Revenue Growth YoY (%)	37.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+364%)	82.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+934%)	158.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1882%)	197.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2372%)	10.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+34%)	9.7% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21%)	76.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+854%)	—	—
EPS Growth YoY (%)	423.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	37.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	23.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	-37.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	436.6% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	18.1% Good ↑ Good Improving Year-over-year change in net income	-53.8% Weak ↓ Weak Declining Year-over-year change in net income	14.3% Fair Fair Year-over-year change in net income	-41.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	52.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-159.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	-66.6% Weak Weak Year-over-year change in free cash flow	5.7% Fair Fair Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	86.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	141.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	104.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	53.5% Excellent Excellent Compound annual revenue growth over 3 years	28.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	84.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	76.4% Excellent Excellent Compound annual revenue growth over 5 years	75.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Operating Margin (%) (%)	17.9% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+20%)	8.5% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-43%)	-11.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-179%)	-33.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-324%)	-125.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-938%)	-93.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-720%)	-114.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-864%)	-138.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1020%)	—
Effective Tax Rate (%) (%)	-77.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	31.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+162%)	8.0% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-33%)	-10.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-186%)	-38.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-423%)	-140.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1274%)	-101.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-945%)	-129.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1182%)	-162.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1451%)	—
FCF Margin (%) (%)	22.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-68.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-61.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-103.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-108.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-125.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-180.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	-2.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	6.59x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.59x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Return on Invested Capital (%)	40.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	16.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	10.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	10.2% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	4.7% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-4.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-48.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	40.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+168%)	15.5% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-18.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-19.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-65.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-534%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-61.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-509%)	12.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Debt to Equity (x)	—	—	—	0.31x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-48%)	0.52x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-14%)	0.33x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-44%)	0.62x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	-0.18x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-129%)	—
Interest Coverage (x)	10.15x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	3.32x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-2.66x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	$-394.81M	$-142.49M	$9.62M	$10.08M	$14.05M	$13.43M	—
Debt / EBITDA (x)	—	—	—	-2.10x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.94x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.40x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.73x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Revenue per Share (USD)	$17.81	$13.29	$7.43	$3.16	$1.14	$1.15	—	—	—
Basic EPS, GAAP (USD)	$5.60	$1.07	$-0.77	$-1.23	$-1.60	$-1.16	—	—	—
Free Cash Flow per Share (USD)	$3.93	$-2.44	$-5.07	$-1.95	$-1.17	$-1.24	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	—	—
Book Value per Share (USD)	$13.81	$6.80	$4.20	$5.83	$2.44	$3.82	—	—	—
Tangible Book Value per Share (USD)	$13.41	$6.39	$3.76	$5.83	$2.44	$3.82	—	—	—
Basic Weighted Avg Shares (shares)	33.99M	33.23M	32.52M	29.56M	27.62M	24.70M	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Working Capital (USD)	$548.48M	$437.30M	$455.72M	$228.63M	$95.47M	$134.89M	$83.89M	$22.24M	—
LT Debt (USD)	—	—	—	$58.70M	$35.20M	$34.66M	$34.15M	$33.67M	—
Total Equity (USD)	$473.10M	$228.60M	$137.20M	$187.38M	$67.85M	$103.89M	$54.65M	$-192.24M	$-168.72M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 28, 2019 10-K ↗	FY 2018 Dec 29, 2018 10-K ↗	FY 2017 Dec 30, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$605.49M	$441.54M	$241.62M	$93.46M	$31.39M	$28.36M	$25.84M	$14.66M	—
Depreciation Expense (USD)	$27.18M	$19.76M	$8.18M	$3.48M	$1.82M	$1.58M	$1.22M	$769.00K	—
Net Income, GAAP (USD)	$190.29M	$35.46M	$-25.03M	$-36.23M	$-44.22M	$-28.75M	$-33.55M	$-23.76M	—
Operating Cash Flow (USD)	$192.84M	$48.80M	$-13.03M	$-45.82M	$-28.86M	$-30.27M	$-32.29M	$-25.98M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

TransMedics Group, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TMDX with peers